sec filing
NASDAQ · AVXL
Anavex Life Sciences Corp.
Healthcare · Biotechnology
$3.27
Down-$0.14 (-4.11%)
Updated Aug 14, 2026, 9:27 AM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 367.21M
- P/E ratio
- -7.28
- Dividend yield
- 0.00%
- 52-week range
- $2.26 – $11.70
- Volume
- 829.93K
- Avg. volume
- 2.3M
Price performance
AVXL price history
1M range · 21 trading sessions · Daily adjusted prices
AVXL closed at $3.27 after 21 trading sessions, up 39.74% for the selected period.
- Last close
- $3.27
- Period change
- +39.74%
- Period low
- $2.34
- Period high
- $3.51
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $3.40 | $3.40 | $3.22 | $3.27 | 829.93K |
| Aug 12, 2026 | $3.50 | $3.57 | $3.40 | $3.41 | 667.08K |
| Aug 11, 2026 | $3.37 | $3.54 | $3.36 | $3.51 | 662.62K |
| Aug 10, 2026 | $3.33 | $3.44 | $3.284 | $3.39 | 668.8K |
| Aug 7, 2026 | $3.33 | $3.40 | $3.32 | $3.34 | 1.05M |
| Aug 6, 2026 | $3.17 | $3.32 | $3.16 | $3.28 | 856.16K |
| Aug 5, 2026 | $3.18 | $3.26 | $3.12 | $3.20 | 1.17M |
| Aug 4, 2026 | $2.94 | $3.30 | $2.935 | $3.15 | 1.98M |
| Aug 3, 2026 | $2.80 | $2.97 | $2.74 | $2.95 | 1.44M |
| Jul 31, 2026 | $2.67 | $2.77 | $2.66 | $2.75 | 1.2M |
| Jul 30, 2026 | $2.51 | $2.71 | $2.51 | $2.70 | 1.25M |
| Jul 29, 2026 | $2.56 | $2.60 | $2.48 | $2.49 | 1.1M |
| Jul 28, 2026 | $2.48 | $2.60 | $2.47 | $2.57 | 775.99K |
| Jul 27, 2026 | $2.41 | $2.5391 | $2.38 | $2.50 | 716.57K |
| Jul 24, 2026 | $2.48 | $2.495 | $2.39 | $2.40 | 1.01M |
| Jul 23, 2026 | $2.48 | $2.555 | $2.46 | $2.48 | 1.18M |
| Jul 22, 2026 | $2.54 | $2.60 | $2.51 | $2.55 | 656.18K |
| Jul 21, 2026 | $2.39 | $2.59 | $2.39 | $2.555 | 829.8K |
| Jul 20, 2026 | $2.41 | $2.45 | $2.37 | $2.42 | 850.67K |
| Jul 17, 2026 | $2.28 | $2.43 | $2.255 | $2.39 | 1.92M |
| Jul 16, 2026 | $2.47 | $2.47 | $2.295 | $2.34 | 763.69K |
Latest AVXL news
The latest Smart Investors Daily articles mentioning AVXL.
Stock researchCompany · Earnings
Loading stock research…